CVS

CVS HEALTH
D

CVS

Arincen56/100B

CVS HEALTH P/E ratio

CVS HEALTH's P/E ratio is 9.68: its share price of 83.87 over its earnings per share of 8.66 over the last twelve months.

Today
9.68
Forward P/E, next 12 months
9.92
PEG ratio
0.18
Median, 5 years
16.49
Low, 5 years
9.40
High, 5 years
202.08

P/E ratio = price ÷ EPS (last 12 months) = 83.87 ÷ 8.66 = 9.68

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Is CVS HEALTH's P/E high compared with its own history?

CVS HEALTH's P/E of 9.7 is near the bottom of its 5-year range (9.4 to 202.1, median 16.5). It is within 5% of its 5-year low. Analysts do not expect slower growth than in recent years, so it is cheaper than its usual level.

Is the price fair? See the whole check

A P/E is compared with the stock's own last five years, not with other companies. Why the market pays more or less (news, rates, the sector) is not in these figures.

P/E ratio by year and by quarter

Fiscal yearPeriod endingP/E ratioForward P/EMarket capNet income
FY2027 · Estimate31 Dec 20279.84———
FY2026 · Estimate31 Dec 202610.42———
Today9.689.92107.27B11.07B
FY202531 Dec 202558.199.86100.55B1.73B
FY202431 Dec 202412.326.7356.52B4.59B
FY202331 Dec 202312.1315.30101.46B8.37B
FY202231 Dec 202228.2610.83122.27B4.33B
FY202131 Dec 202117.038.27136.07B7.99B
FY202031 Dec 202012.438.2789.40B7.19B
FY201931 Dec 201914.589.9896.65B6.63B
FY201831 Dec 2018—9.3168.40B-596.00M
FY201731 Dec 201711.1710.3873.95B6.62B
FY201631 Dec 201615.9213.4384.67B5.32B
FY201531 Dec 201520.8616.84109.31B5.24B
FY201431 Dec 201424.0818.64111.82B4.64B
FY201331 Dec 201318.9716.1687.10B4.59B
FY201231 Dec 201215.9112.7661.45B3.86B
FY201131 Dec 201115.7812.4054.56B3.46B
FY201031 Dec 201013.8812.8347.53B3.42B
FY200931 Dec 200912.5011.9346.19B3.70B
FY200831 Dec 200812.8311.2341.21B3.21B
FY200731 Dec 200720.0216.3652.80B2.64B
FY200631 Dec 200618.5316.2925.36B1.37B
FY200531 Dec 200517.5018.2321.44B1.22B
FY200431 Dec 200418.8117.2118.04B959.30M
FY200331 Dec 200316.7418.4314.19B847.30M
FY200231 Dec 200213.6813.019.80B716.60M
FY200131 Dec 200127.9918.7311.56B413.20M
FY200031 Dec 200031.4338.3923.44B746.00M
FY199931 Dec 199924.5722.4015.61B635.10M
FY199831 Dec 199855.3738.7321.29B384.50M
FY199731 Dec 1997113.6127.6212.03B105.90M
FY199631 Dec 199621.1822.984.41B208.20M
FY199531 Dec 1995——3.32B-572.80M
FY199431 Dec 199410.61—3.26B307.50M
FY199331 Dec 199316.08—5.33B331.80M
FY199231 Dec 199235.78—5.58B156.00M
FY199131 Dec 199113.28—4.60B346.70M
FY199031 Dec 199011.19—4.31B385.30M
FY198931 Dec 198912.07—4.81B398.10M
FY198831 Dec 198811.43—4.05B354.50M
FY198731 Dec 198710.04—2.87B285.40M
FY198631 Dec 198612.27—2.92B238.30M
FY198531 Dec 198513.00—2.73B210.20M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

See also:Market cap,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about CVS HEALTH's P/E ratio

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.